Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1993 Feb 15;148(4):521–538.

Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on the Periodic Health Examination.

PMCID: PMC1490508  PMID: 8431815

Full text

PDF
521

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agner E., Hansen P. F. Fasting serum cholesterol and triglycerides in a ten-year prospective study in old age. Acta Med Scand. 1983;214(1):33–41. doi: 10.1111/j.0954-6820.1983.tb08567.x. [DOI] [PubMed] [Google Scholar]
  2. Anderson K. M., Castelli W. P., Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987 Apr 24;257(16):2176–2180. doi: 10.1001/jama.257.16.2176. [DOI] [PubMed] [Google Scholar]
  3. Barrett-Connor E., Suarez L., Khaw K., Criqui M. H., Wingard D. L. Ischemic heart disease risk factors after age 50. J Chronic Dis. 1984;37(12):903–908. doi: 10.1016/0021-9681(84)90066-3. [DOI] [PubMed] [Google Scholar]
  4. Benfante R., Reed D. Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA. 1990 Jan 19;263(3):393–396. [PubMed] [Google Scholar]
  5. Blank D. W., Hoeg J. M., Kroll M. H., Ruddel M. E. The method of determination must be considered in interpreting blood cholesterol levels. JAMA. 1986 Nov 28;256(20):2867–2870. [PubMed] [Google Scholar]
  6. Bolton-Smith C., Woodward M., Smith W. C., Tunstall-Pedoe H. Dietary and non-dietary predictors of serum total and HDL-cholesterol in men and women: results from the Scottish Heart Health Study. Int J Epidemiol. 1991 Mar;20(1):95–104. doi: 10.1093/ije/20.1.95. [DOI] [PubMed] [Google Scholar]
  7. Bookstein L., Gidding S. S., Donovan M., Smith F. A. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines. Arch Intern Med. 1990 Aug;150(8):1653–1657. [PubMed] [Google Scholar]
  8. Breckenridge W. C. The role of lipoproteins and apolipoproteins in prediction of coronary heart disease risk. Clin Invest Med. 1990 Aug;13(4):196–201. [PubMed] [Google Scholar]
  9. Brunner D., Weisbort J., Meshulam N., Schwartz S., Gross J., Saltz-Rennert H., Altman S., Loebl K. Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: twenty-year follow-up of the Donolo-Tel Aviv Prospective Coronary Artery Disease Study. Am J Cardiol. 1987 Jun 1;59(15):1271–1276. doi: 10.1016/0002-9149(87)90903-9. [DOI] [PubMed] [Google Scholar]
  10. Burr M. L., Fehily A. M., Gilbert J. F., Rogers S., Holliday R. M., Sweetnam P. M., Elwood P. C., Deadman N. M. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989 Sep 30;2(8666):757–761. doi: 10.1016/s0140-6736(89)90828-3. [DOI] [PubMed] [Google Scholar]
  11. Bush T. L., Barrett-Connor E., Cowan L. D., Criqui M. H., Wallace R. B., Suchindran C. M., Tyroler H. A., Rifkind B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987 Jun;75(6):1102–1109. doi: 10.1161/01.cir.75.6.1102. [DOI] [PubMed] [Google Scholar]
  12. Caggiula A. W., Christakis G., Farrand M., Hulley S. B., Johnson R., Lasser N. L., Stamler J., Widdowson G. The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipids. Prev Med. 1981 Jul;10(4):443–475. doi: 10.1016/0091-7435(81)90060-8. [DOI] [PubMed] [Google Scholar]
  13. Carlson L. A., Böttiger L. E. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand. 1985;218(2):207–211. doi: 10.1111/j.0954-6820.1985.tb08848.x. [DOI] [PubMed] [Google Scholar]
  14. Chen Z., Peto R., Collins R., MacMahon S., Lu J., Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ. 1991 Aug 3;303(6797):276–282. doi: 10.1136/bmj.303.6797.276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Choudhury S., Jackson P., Katan M. B., Marenah C. B., Cortese C., Miller N. E., Lewis B. A multifactorial diet in the management of hyperlipidaemia. Atherosclerosis. 1984 Jan;50(1):93–103. doi: 10.1016/0021-9150(84)90011-x. [DOI] [PubMed] [Google Scholar]
  16. Corday E., Rydén L. Why some physicians have concerns about the cholesterol awareness program. J Am Coll Cardiol. 1989 Feb;13(2):497–502. doi: 10.1016/0735-1097(89)90531-7. [DOI] [PubMed] [Google Scholar]
  17. Cullen K., Stenhouse N. S., Wearne K. L., Welborn T. A. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study. J Chronic Dis. 1983;36(5):371–377. doi: 10.1016/0021-9681(83)90169-8. [DOI] [PubMed] [Google Scholar]
  18. Curzio J. L., Kennedy S. S., Elliott H. L., Farish E., Barnes J. F., Howie C. A., Seymour J., Reid J. L. Hypercholesterolaemia in treated hypertensives: a controlled trial of intensive dietary advice. J Hypertens Suppl. 1989 Dec;7(6):S254–S255. doi: 10.1097/00004872-198900076-00123. [DOI] [PubMed] [Google Scholar]
  19. Davis C. E., Rifkind B. M., Brenner H., Gordon D. J. A single cholesterol measurement underestimates the risk of coronary heart disease. An empirical example from the Lipid Research Clinics Mortality Follow-up Study. JAMA. 1990 Dec 19;264(23):3044–3046. [PubMed] [Google Scholar]
  20. Denke M. A., Grundy S. M. Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann Intern Med. 1990 May 15;112(10):780–792. doi: 10.7326/0003-4819-112-10-780. [DOI] [PubMed] [Google Scholar]
  21. Dennison B. A., Kikuchi D. A., Srinivasan S. R., Webber L. S., Berenson G. S. Serum total cholesterol screening for the detection of elevated low-density lipoprotein in children and adolescents: the Bogalusa Heart Study. Pediatrics. 1990 Apr;85(4):472–479. [PubMed] [Google Scholar]
  22. Dorr A. E., Gundersen K., Schneider J. C., Jr, Spencer T. W., Martin W. B. Colestipol hydrochloride in hypercholesterolemic patients--effect on serum cholesterol and mortality. J Chronic Dis. 1978 Jan;31(1):5–14. doi: 10.1016/0021-9681(78)90076-0. [DOI] [PubMed] [Google Scholar]
  23. Ehnholm C., Huttunen J. K., Pietinen P., Leino U., Mutanen M., Kostiainen E., Pikkarainen J., Dougherty R., Iacono J., Puska P. Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med. 1982 Sep 30;307(14):850–855. doi: 10.1056/NEJM198209303071403. [DOI] [PubMed] [Google Scholar]
  24. Farquhar J. W., Fortmann S. P., Flora J. A., Taylor C. B., Haskell W. L., Williams P. T., Maccoby N., Wood P. D. Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA. 1990 Jul 18;264(3):359–365. [PubMed] [Google Scholar]
  25. Feldman W. Routine cholesterol surveillance in childhood. Pediatrics. 1990 Jul;86(1):150–151. [PubMed] [Google Scholar]
  26. Fihn S. D. A prudent approach to control of cholesterol levels. JAMA. 1987 Nov 6;258(17):2416–2418. [PubMed] [Google Scholar]
  27. Forette B., Tortrat D., Wolmark Y. Cholesterol as risk factor for mortality in elderly women. Lancet. 1989 Apr 22;1(8643):868–870. doi: 10.1016/s0140-6736(89)92865-1. [DOI] [PubMed] [Google Scholar]
  28. Frantz I. D., Jr, Dawson E. A., Ashman P. L., Gatewood L. C., Bartsch G. E., Kuba K., Brewer E. R. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesota Coronary Survey. Arteriosclerosis. 1989 Jan-Feb;9(1):129–135. doi: 10.1161/01.atv.9.1.129. [DOI] [PubMed] [Google Scholar]
  29. Fraser G. E., Swannell R. J. Diet and serum cholesterol in Seventh-day Adventists: a cross-sectional study showing significant relationships. J Chronic Dis. 1981;34(9-10):487–501. doi: 10.1016/0021-9681(81)90009-6. [DOI] [PubMed] [Google Scholar]
  30. Frick M. H., Elo O., Haapa K., Heinonen O. P., Heinsalmi P., Helo P., Huttunen J. K., Kaitaniemi P., Koskinen P., Manninen V. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. doi: 10.1056/NEJM198711123172001. [DOI] [PubMed] [Google Scholar]
  31. Fyrö K., Bodegård G. Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatr Scand. 1987 Jan;76(1):107–114. doi: 10.1111/j.1651-2227.1987.tb10424.x. [DOI] [PubMed] [Google Scholar]
  32. Garcia R. E., Moodie D. S. Routine cholesterol surveillance in childhood. Pediatrics. 1989 Nov;84(5):751–755. [PubMed] [Google Scholar]
  33. Ginsberg H. N., Barr S. L., Gilbert A., Karmally W., Deckelbaum R., Kaplan K., Ramakrishnan R., Holleran S., Dell R. B. Reduction of plasma cholesterol levels in normal men on an American Heart Association Step 1 diet or a Step 1 diet with added monounsaturated fat. N Engl J Med. 1990 Mar 1;322(9):574–579. doi: 10.1056/NEJM199003013220902. [DOI] [PubMed] [Google Scholar]
  34. Gofman J. W., Young W., Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 1966 Oct;34(4):679–697. doi: 10.1161/01.cir.34.4.679. [DOI] [PubMed] [Google Scholar]
  35. Gordon T., Castelli W. P., Hjortland M. C., Kannel W. B., Dawber T. R. Predicting coronary heart disease in middle-aged and older persons. The Framington study. JAMA. 1977 Aug 8;238(6):497–499. [PubMed] [Google Scholar]
  36. Gordon T., Kannel W. B., Castelli W. P., Dawber T. R. Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med. 1981 Aug;141(9):1128–1131. [PubMed] [Google Scholar]
  37. Grundy S. M., Barrett-Connor E., Rudel L. L., Miettinen T., Spector A. A. Workshop on the impact of dietary cholesterol on plasma lipoproteins and atherogenesis. Arteriosclerosis. 1988 Jan-Feb;8(1):95–101. doi: 10.1161/01.atv.8.1.95. [DOI] [PubMed] [Google Scholar]
  38. Grundy S. M. Cholesterol and coronary heart disease. A new era. JAMA. 1986 Nov 28;256(20):2849–2858. [PubMed] [Google Scholar]
  39. Grundy S. M., Nix D., Whelan M. F., Franklin L. Comparison of three cholesterol-lowering diets in normolipidemic men. JAMA. 1986 Nov 7;256(17):2351–2355. [PubMed] [Google Scholar]
  40. Harris T., Cook E. F., Kannel W. B., Goldman L. Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study. J Am Geriatr Soc. 1988 Nov;36(11):1023–1028. doi: 10.1111/j.1532-5415.1988.tb04370.x. [DOI] [PubMed] [Google Scholar]
  41. Hegsted D. M., McGandy R. B., Myers M. L., Stare F. J. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr. 1965 Nov;17(5):281–295. doi: 10.1093/ajcn/17.5.281. [DOI] [PubMed] [Google Scholar]
  42. Hjermann I., Velve Byre K., Holme I., Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet. 1981 Dec 12;2(8259):1303–1310. doi: 10.1016/s0140-6736(81)91338-6. [DOI] [PubMed] [Google Scholar]
  43. Hoefler G., Harnoncourt F., Paschke E., Mirtl W., Pfeiffer K. H., Kostner G. M. Lipoprotein Lp(a). A risk factor for myocardial infarction. Arteriosclerosis. 1988 Jul-Aug;8(4):398–401. doi: 10.1161/01.atv.8.4.398. [DOI] [PubMed] [Google Scholar]
  44. Irvine M. J., Garner D. M., Olmsted M. P., Logan A. G. Personality differences between hypertensive and normotensive individuals: influence of knowledge of hypertension status. Psychosom Med. 1989 Sep-Oct;51(5):537–549. doi: 10.1097/00006842-198909000-00005. [DOI] [PubMed] [Google Scholar]
  45. Isles C. G., Hole D. J., Gillis C. R., Hawthorne V. M., Lever A. F. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ. 1989 Apr 8;298(6678):920–924. doi: 10.1136/bmj.298.6678.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Iso H., Jacobs D. R., Jr, Wentworth D., Neaton J. D., Cohen J. D. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med. 1989 Apr 6;320(14):904–910. doi: 10.1056/NEJM198904063201405. [DOI] [PubMed] [Google Scholar]
  47. Johansen H., Semenciw R., Morrison H., Mao Y., Verdier P., Smith M. E., Wigle D. T. Important risk factors for death in adults: a 10-year follow-up of the Nutrition Canada survey cohort. CMAJ. 1987 Apr 15;136(8):823–828. [PMC free article] [PubMed] [Google Scholar]
  48. Jones G. J., Hewitt D., Godin G. J., Breckenridge W. C., Bird J., Mishkel M. A., Steiner G., Little J. A. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population. Can Med Assoc J. 1980 Jan 12;122(1):37-8, 40-6. [PMC free article] [PubMed] [Google Scholar]
  49. Kagan A., Harris B. R., Winkelstein W., Jr, Johnson K. G., Kato H., Syme S. L., Rhoads G. G., Gay M. L., Nichaman M. Z., Hamilton H. B. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis. 1974 Sep;27(7-8):345–364. doi: 10.1016/0021-9681(74)90014-9. [DOI] [PubMed] [Google Scholar]
  50. Kannel W. B., Castelli W. P., Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med. 1979 Jan;90(1):85–91. doi: 10.7326/0003-4819-90-1-85. [DOI] [PubMed] [Google Scholar]
  51. Kannel W. B. Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis. 1974 Jul-Aug;17(1):5–24. doi: 10.1016/0033-0620(74)90034-6. [DOI] [PubMed] [Google Scholar]
  52. Keys A., Parlin R. W. Serum cholesterol response to changes in dietary lipids. Am J Clin Nutr. 1966 Sep;19(3):175–181. doi: 10.1093/ajcn/19.3.175. [DOI] [PubMed] [Google Scholar]
  53. Kinlay S., Heller R. F. Selective screening for high cholesterol in Australian general practice: the Newcastle Cholesterol Prediction Study. J Gen Intern Med. 1990 Jan-Feb;5(1):1–8. doi: 10.1007/BF02602300. [DOI] [PubMed] [Google Scholar]
  54. Kromhout D., Bosschieter E. B., de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985 May 9;312(19):1205–1209. doi: 10.1056/NEJM198505093121901. [DOI] [PubMed] [Google Scholar]
  55. Kwiterovich P. O., Jr, Heiss G., Johnson N., Chase G. A., Tamir I., Rifkind B. Assessment of plasma total cholesterol as a test to detect elevated low density (beta) lipoprotein cholesterol levels (type IIa hyperlipoproteinemia) in young subjects from a population-based sample. Am J Epidemiol. 1982 Feb;115(2):192–204. doi: 10.1093/oxfordjournals.aje.a113291. [DOI] [PubMed] [Google Scholar]
  56. Lapidus L., Andersson H., Bengtsson C., Bosaeus I. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Clin Nutr. 1986 Oct;44(4):444–448. doi: 10.1093/ajcn/44.4.444. [DOI] [PubMed] [Google Scholar]
  57. Laupacis A., Sackett D. L., Roberts R. S. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988 Jun 30;318(26):1728–1733. doi: 10.1056/NEJM198806303182605. [DOI] [PubMed] [Google Scholar]
  58. Lee J., Lauer R. M., Clarke W. R. Lipoproteins in the progeny of young men with coronary artery disease: children with increased risk. Pediatrics. 1986 Aug;78(2):330–337. [PubMed] [Google Scholar]
  59. Leren P. The Oslo diet-heart study. Eleven-year report. Circulation. 1970 Nov;42(5):935–942. doi: 10.1161/01.cir.42.5.935. [DOI] [PubMed] [Google Scholar]
  60. Lifshitz F., Moses N. Growth failure. A complication of dietary treatment of hypercholesterolemia. Am J Dis Child. 1989 May;143(5):537–542. [PubMed] [Google Scholar]
  61. Löwik M. R., Hulshof K. F., Odink J., Schrijver J., Spanhaak S., van Houten P. Cholesterol and mortality in elderly women. Lancet. 1989 Jul 1;2(8653):41–41. doi: 10.1016/s0140-6736(89)90273-0. [DOI] [PubMed] [Google Scholar]
  62. MANTEL N., HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959 Apr;22(4):719–748. [PubMed] [Google Scholar]
  63. Macdonald L. A., Sackett D. L., Haynes R. B., Taylor D. W. Labelling in hypertension: a review of the behavioural and psychological consequences. J Chronic Dis. 1984;37(12):933–942. doi: 10.1016/0021-9681(84)90070-5. [DOI] [PubMed] [Google Scholar]
  64. Malenka D. J., Baron J. A. Cholesterol and coronary heart disease. The importance of patient-specific attributable risk. Arch Intern Med. 1988 Oct;148(10):2247–2252. [PubMed] [Google Scholar]
  65. Martin M. J., Hulley S. B., Browner W. S., Kuller L. H., Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986 Oct 25;2(8513):933–936. doi: 10.1016/s0140-6736(86)90597-0. [DOI] [PubMed] [Google Scholar]
  66. Mattson F. H., Grundy S. M. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res. 1985 Feb;26(2):194–202. [PubMed] [Google Scholar]
  67. McGee D. L., Reed D. M., Yano K., Kagan A., Tillotson J. Ten-year incidence of coronary heart disease in the Honolulu Heart Program. Relationship to nutrient intake. Am J Epidemiol. 1984 May;119(5):667–676. doi: 10.1093/oxfordjournals.aje.a113788. [DOI] [PubMed] [Google Scholar]
  68. Mensink R. P., Katan M. B. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med. 1989 Aug 17;321(7):436–441. doi: 10.1056/NEJM198908173210705. [DOI] [PubMed] [Google Scholar]
  69. Miettinen M., Turpeinen O., Karvonen M. J., Elosuo R., Paavilainen E. Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet. 1972 Oct 21;2(7782):835–838. doi: 10.1016/s0140-6736(72)92208-8. [DOI] [PubMed] [Google Scholar]
  70. Miettinen T. A., Huttunen J. K., Naukkarinen V., Strandberg T., Mattila S., Kumlin T., Sarna S. Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. JAMA. 1985 Oct 18;254(15):2097–2102. [PubMed] [Google Scholar]
  71. Morgan P. P., Wigle D. T. Medical care and th declining rates of death due to heart disease and stroke. Can Med Assoc J. 1981 Nov 1;125(9):953–954. [PMC free article] [PubMed] [Google Scholar]
  72. Muldoon M. F., Manuck S. B., Matthews K. A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990 Aug 11;301(6747):309–314. doi: 10.1136/bmj.301.6747.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Oliver M. F. Prevention of coronary heart disease--propaganda, promises, problems, and prospects. Circulation. 1986 Jan;73(1):1–9. doi: 10.1161/01.cir.73.1.1. [DOI] [PubMed] [Google Scholar]
  74. Orchard T. J., Donahue R. P., Kuller L. H., Hodge P. N., Drash A. L. Cholesterol screening in childhood: does it predict adult hypercholesterolemia? The Beaver County experience. J Pediatr. 1983 Nov;103(5):687–691. doi: 10.1016/s0022-3476(83)80458-2. [DOI] [PubMed] [Google Scholar]
  75. PIPER J., ORRILD L. Essential familial hypercholesterolemia and xanthomatosis; follow-up study of twelve Danish families. Am J Med. 1956 Jul;21(1):34–46. doi: 10.1016/0002-9343(56)90006-7. [DOI] [PubMed] [Google Scholar]
  76. Pearce M. L., Dayton S. Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet. 1971 Mar 6;1(7697):464–467. doi: 10.1016/s0140-6736(71)91086-5. [DOI] [PubMed] [Google Scholar]
  77. Puska P., Nissinen A., Tuomilehto J., Salonen J. T., Koskela K., McAlister A., Kottke T. E., Maccoby N., Farquhar J. W. The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health. 1985;6:147–193. doi: 10.1146/annurev.pu.06.050185.001051. [DOI] [PubMed] [Google Scholar]
  78. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ. 1992 Jul 4;305(6844):15–19. doi: 10.1136/bmj.305.6844.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Reed D. M., MacLean C. J., Hayashi T. Predictors of atherosclerosis in the Honolulu Heart Program. I. Biologic, dietary, and lifestyle characteristics. Am J Epidemiol. 1987 Aug;126(2):214–225. doi: 10.1093/aje/126.2.214. [DOI] [PubMed] [Google Scholar]
  80. Rogers M. C. Sir John Scott Burdon-Sanderson (1828-1905): a pioneer in electrophysiology. Circulation. 1969 Jul;40(1):1–2. doi: 10.1161/01.cir.40.1.1. [DOI] [PubMed] [Google Scholar]
  81. Rose G., Heller R. F., Pedoe H. T., Christie D. G. Heart disease prevention project: a randomised controlled trial in industry. Br Med J. 1980 Mar 15;280(6216):747–751. doi: 10.1136/bmj.280.6216.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Schatzkin A., Hoover R. N., Taylor P. R., Ziegler R. G., Carter C. L., Larson D. B., Licitra L. M. Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey. Lancet. 1987 Aug 8;2(8554):298–301. doi: 10.1016/s0140-6736(87)90890-7. [DOI] [PubMed] [Google Scholar]
  83. Shekelle R. B., Stamler J. Dietary cholesterol and ischaemic heart disease. Lancet. 1989 May 27;1(8648):1177–1179. doi: 10.1016/s0140-6736(89)92759-1. [DOI] [PubMed] [Google Scholar]
  84. Shipley M. J., Pocock S. J., Marmot M. G. Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. BMJ. 1991 Jul 13;303(6794):89–92. doi: 10.1136/bmj.303.6794.89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Snowdon D. A., Phillips R. L., Fraser G. E. Meat consumption and fatal ischemic heart disease. Prev Med. 1984 Sep;13(5):490–500. doi: 10.1016/0091-7435(84)90017-3. [DOI] [PubMed] [Google Scholar]
  86. Sorenson J. R., Levy H. L., Mangione T. W., Sepe S. J. Parental response to repeat testing of infants with 'false-positive' results in a newborn screening program. Pediatrics. 1984 Feb;73(2):183–187. [PubMed] [Google Scholar]
  87. Staessen J., Amery A., Birkenhäger W., Bulpitt C., Clement D., de Leeuw P., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R. Is a high serum cholesterol level associated with longer survival in elderly hypertensives? J Hypertens. 1990 Aug;8(8):755–761. doi: 10.1097/00004872-199008000-00010. [DOI] [PubMed] [Google Scholar]
  88. Stallones R. A. Ischemic heart disease and lipids in blood and diet. Annu Rev Nutr. 1983;3:155–185. doi: 10.1146/annurev.nu.03.070183.001103. [DOI] [PubMed] [Google Scholar]
  89. Stampfer M. J., Sacks F. M., Salvini S., Willett W. C., Hennekens C. H. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991 Aug 8;325(6):373–381. doi: 10.1056/NEJM199108083250601. [DOI] [PubMed] [Google Scholar]
  90. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. doi: 10.1056/NEJM198904063201407. [DOI] [PubMed] [Google Scholar]
  91. Strandberg T. E., Salomaa V. V., Naukkarinen V. A., Vanhanen H. T., Sarna S. J., Miettinen T. A. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA. 1991 Sep 4;266(9):1225–1229. [PubMed] [Google Scholar]
  92. Tran Z. V., Weltman A. Differential effects of exercise on serum lipid and lipoprotein levels seen with changes in body weight. A meta-analysis. JAMA. 1985 Aug 16;254(7):919–924. [PubMed] [Google Scholar]
  93. Truett J., Cornfield J., Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis. 1967 Jul;20(7):511–524. doi: 10.1016/0021-9681(67)90082-3. [DOI] [PubMed] [Google Scholar]
  94. Uemura K., Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 1950. World Health Stat Q. 1988;41(3-4):155–178. [PubMed] [Google Scholar]
  95. Virkkunen M. Serum cholesterol levels in homicidal offenders. A low cholesterol level is connected with a habitually violent tendency under the influence of alcohol. Neuropsychobiology. 1983;10(2-3):65–69. doi: 10.1159/000117987. [DOI] [PubMed] [Google Scholar]
  96. Weisweiler P., Janetschek P., Schwandt P. Influence of polyunsaturated fats and fat restriction on serum lipoproteins in humans. Metabolism. 1985 Jan;34(1):83–87. doi: 10.1016/0026-0495(85)90065-4. [DOI] [PubMed] [Google Scholar]
  97. Wilhelmsen L., Berglund G., Elmfeldt D., Tibblin G., Wedel H., Pennert K., Vedin A., Wilhelmsson C., Werkö L. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J. 1986 Apr;7(4):279–288. doi: 10.1093/oxfordjournals.eurheartj.a062065. [DOI] [PubMed] [Google Scholar]
  98. Williams R. R., Hasstedt S. J., Wilson D. E., Ash K. O., Yanowitz F. F., Reiber G. E., Kuida H. Evidence that men with familial hypercholesterolemia can avoid early coronary death. An analysis of 77 gene carriers in four Utah pedigrees. JAMA. 1986 Jan 10;255(2):219–224. [PubMed] [Google Scholar]
  99. Williams W. R., Schneider K. A., Borhani N. O., Schnaper H. W., Slotkoff L. M., Ellefson R. D. The relationship between diuretics and serum cholesterol in Hypertension Detection and Follow-up Program participants. Am J Prev Med. 1986 Sep-Oct;2(5):248–255. [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES